Festival of Genomics Boston
- Start Date:
- Tuesday, 3 October, 2017
- End Date:
- Wednesday, 4 October, 2017 5:00pm
- Health & Nutrition
Across the two days, four core themes will be addressed by high profile speakers from respected organizations. Listen, discuss and get in on the debates about Personalizing Medicine, Precision Therapeutics, Enabling Data and Research and Development. We know knowledge is power and different experiences can help you learn and retain information. Therefore we have 5 stages oozing with sessions of all different shapes, sizes and formats.
Check out all of them to get the full 360 experience of the Festival. Some of our exciting features for 2017 include: *NEW* Live Lounge: Pull up a beanbag and tune into bite sized insights from patients, clinicians, and leading solution providers. The stage will feature: Product demonstrations from solution providers; Disorder Rare Disease Short Film Festival; Rare Disease Patient Track built by Rare New England and so much more...
Talkaoke: Join our unique "flying saucer of chat" to explore the interconnection of the many essential themes, ideas and opinions setting the Festival abuzz. Join key speakers at the table to have your say! *NEW* Game of Genomes: Carl Zimmer, New York Times Columnist, is on a quest to understand his genome. With a circle of advisers, Carl will journey beyond the wall to explore the cutting-edge research changing our perception of who we are.
Join him on his hunt for answers! *NEW* Buyer's Concierge: Looking to source new equipment or solutions? Our FREE service arranges 1-2-1 meetings matching your needs with prospective suppliers, saving you time and effort. The Festival Pass is $59 and gives you access to all content, all features and all exhibitors across the two days. Register online at www.festivalofgenomicsboston.com/evvnt Speakers: Heidi Rehm - Partners Healthcare Personalized Medicine, David Bick - The Smith Family Clinic for Genomic Medicine, Noel Burtt - Broad Institute, Toby Bloom - New York Genome Center, Manolis Kellis - Broad Institute of MIT and Harvard, Mark Gerstein - Yale University, Anthony Philippakis - Broad Institute, Enoch Huang - Pfizer Worldwide RandD, Goncalo Abecasis - University of Michigan, Cory McLean - Google Brain, Andy Plump - Takeda, Sally John - Biogen, Lon Cardon - GSK, Robert Plenge - Celgene, Alan Balch - Patient Advocate Foundation, Alan Holbrook - National Organization for Rare Disorders, Amel Karaa - Massachusetts General Hospital, Amy Abernethy - Flatiron Health, Cameron Myhrvold - Broad Institute, Carl Zimmer - New York Times, Catherine Freije - Harvard University/ Broad Institute, Christine Lu - Harvard Medical School Department of Population Medicine and Harvard Pilgrim Health Care Institute, Dave Messina - Cofactor Genomics, David Henderson - Axio Research, Emma Huang - Janssen RandD, Gaurav Singal - Foundation Medicine, George Annas - Boston University School of Public Health, Gillian Browne - MilliporeSigma, Heather Norwood - International FOXG1 Foundation, Janna Hutz - Eisai AiM Institute, Jeff Reid - Regeneron Genetics Center, Jessica Shriver - Rare New England, Jochen Lennerz - Massachusetts General Hospital, John Campbell - GlaxoSmithKline, Karen Gripp - Al DuPont Hospital for Children, Lars Jorgensen - Ontario Institute for Cancer Research, Laura Parham - PAREXEL International, Lisa Deck - Sisters@Heart, Mary-Frances Garber - Healing: Private Practice, Matthieu Schapranow - Hasso Plattner Institute, Mera Tilley - Pfizer, Michael Joyner - Mayo Clinic, Nadeem Sarwar - Eisai AiM Institute, Nicholas Confuorto - Nanostring Technologies, Nicholas Dracopoli - Janssen Pharmaceuticals, Nikolai Slavov - Northeastern University, Niven Narain - Berg, Pat Furlong - Parent Project Muscular Dystrophy, Shanrong Zhao - Pfizer, Shawn Sweeney - AACR, Sheila Sutti - Brigham and Women's Hospital, Zivana Tezak - FDA
Boston Convention and Exhibition Center,
415 Summer St,
Conference organized by Front Line Genomics